Pharmacokinetics of drugs in cachectic patients: a systematic review.
Cachexia is a weight-loss process caused by an underlying chronic disease such as cancer, chronic heart failure, chronic obstructive pulmonary disease, or rheumatoid arthritis. It leads to changes in body structure and function that may influence the pharmacokinetics of drugs. Changes in gut functio...
Saved in:
| Main Authors: | Katja Trobec, Mojca Kerec Kos, Stephan von Haehling, Jochen Springer, Stefan D Anker, Mitja Lainscak |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2013-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0079603 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
External validation of population pharmacokinetic models of gentamicin in paediatric population from preterm newborns to adolescents
by: Črček Mateja, et al.
Published: (2023-06-01) -
Adverse drug reactions in the ambulatory internal patients at the emergency department: Focus on causality assessment and drug-drug interactions
by: Verbič Matej Dobravc, et al.
Published: (2023-06-01) -
Clinico – Hemato and Biochemical Study of Anemia in Cachectic Cattle in Baghdad
by: Baghdad Science Journal
Published: (2011-12-01) -
Intratumor HIF-1α modulates production of a cachectic ligand to cause host wasting
by: Gen Xiao, et al.
Published: (2025-06-01) -
The AMPK agonist 5‐aminoimidazole‐4‐carboxamide ribonucleotide (AICAR), but not metformin, prevents inflammation‐associated cachectic muscle wasting
by: Derek T Hall, et al.
Published: (2018-05-01)